Lv5134
1542 积分 2023-12-04 加入
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
12天前
已完结
Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes
23天前
已关闭
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
27天前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
27天前
已完结
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT
30天前
已关闭
The therapeutic age of the neonatal Fc receptor
1个月前
已完结
The NCI-MATCH trial: lessons for precision oncology
1个月前
已完结
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
2个月前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
2个月前
已完结
SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, superior bystander killing effect and favorable safety profiles
3个月前
已完结
皖公网安备34019202002308
